To further evaluate RALA as a potential prognostic biomarker we utilized a commercially available tissue microarray (TMA) containing breast cancer patient samples encompassing all subtypes as well as a TMA comprised of only TNBC samples constructed at our institution (Supplemental Table 1). This evidence concerns the gene RALA and breast cancer.